Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

Paused · Phase 4

Conditions studied: Acute Coronary Syndrome

In brief

The study aims to demonstrate that a simple intravenous insulin algorithm can be implemented in Latin America and will result in safe and better glucose control in patients with Acute Coronary Syndrome (ACS) compared with SC insulin.

Key facts

Study ID

NCT01151176

Run by

Universidade Positivo

People needed

130

Starts

2012-08-01

Expected to finish

2013-12-01

Last updated by the study team

2012-06-19

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female
• Age 18 or older
• Evidence of AMI within the last 24 h (troponin-T >0.1mcg/l) or electrographic criteria of ST-segment elevation in two limb leads)
• Evidence of Unstable Angina
• Blood glucose >180mg/dL at admission with or without preexisting diabetes
• Willing to give informed consent
• Access to telephone communications after hospital discharge

You may not qualify if…

• Under 18 years of age
• Pregnant or lactating female
• Diabetes ketoacidosis
• Heart failure
• Cardiogenic shock

Where it is running

• Emory University School of Medicine — Atlanta, Georgia, United States
• Hospital Cruz Vermelha Brasileira-Filial do Estado do Paraná — Curitiba, Paraná, Brazil

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.